Healthy Clinical Trial
Official title:
Effects of Cerebellar Transcranial Direct Current Stimulation (ctDCS) on Motor Learning of Healthy Individuals
A crossover trial with healthy volunteers will be conducted. Three sessions will be performed with at least 48 hours washout period to minimize carry-over effects. In each session, volunteers will be submitted to: fatigue and attention levels evaluation, handwriting test, serial reaction time task (SRTT) before and after ctDCS conditions and after session, a performance perception evaluation.
A crossover, pseudo-randomized, sham-controlled and triple blind will be performed in order
to evaluate ctDCS effects on motor learning, since evidence pointed to the crucial role of
cerebellum on motor behavior. A non-involved research will conduct a pseudo-randomization
(www.randomization.com) to warrant the counterbalanced sessions order and the allocation
concealment. Volunteers, researchers and statistical analysis will be blinded to ctDCS
condition.
After given prior informed consent, volunteers will be submitted to three experimental
sessions: anodal ctDCS, cathodal ctDCS and sham ctDCS. Fatigue and attention levels,
handwriting test and SRTT will be performed before and after stimulation. In addition,
performance perception evaluation will be assessed at the end of session.
Electrical current will be delivered through a DC stimulator (NeuroConn Plus, Germany) using
a pair of saline-soaked sponge electrodes (surface 35cm²). The active electrode (anode or
cathode) will be placed over the left cerebellum (3 cm lateral to the inion) and the
reference, over the left arm with current intensity of 2mA, fade in and fade out of 10
seconds, during 20 minutes. Sham tDCS has been used in several studies to evaluate active
tDCS effects.
Sham ctDCS will be applied using the same electrodes placement and parameter settings of
cathodal ctDCS however, stimulation will last only 30 seconds but volunteers will be with
electrodes montage for 20 minutes. Because the device will be automatically turned off
without volunteer's perception, early sensations (mild to moderate tingling) on stimulation
site will be experienced without inducing any modulatory effects. Moreover, after each ctDCS
session, an adverse effects questionnaire will be applied.
Fatigue and attention levels will be measured through an analogue scale graded from 0 to 10,
where 0 means lower fatigue or attention levels and 10, the higher fatigue or attention
levels.
Handwriting test: volunteers will be instructed to write six words with digital pen using the
non-dominant hand on a tablet provided with analysis software system (MovAlyzer, EUA). The
task will be performed spontaneously, without any instruction bias during writing activity.
Each session has different word sequences but the difficulty level will be maintained (six
words, two of them with 4, 6 and 8 letters).
SRTT: will be performed through software with visual stimuli presented on a computer screen
in four different positions. Volunteer must press, with the non-dominant hand, a
corresponding key with a predetermined finger as soon as possible when a highlighted star
appears on the screen. The test comprises eight blocks with 120 trials each. Implicit motor
learning is measured by performance changes between the blocks 5, 6 and 7.
Performance perception evaluation: in order to correlate stimulation type to the conscious
improvement on motor task performance (SRTT and handwriting test) will be asked in the end of
each session: "Regarding today's session, comparing your motor performance before and after
cerebellar stimulation, you consider that you were better, worse or the same as before?"
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
| Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
| Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
| Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
| Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
| Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
| Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
| Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
| Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
| Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
| Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
| Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
| Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
| Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
| Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
| Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |